Clinical trial
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
NCT02209051 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 29 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcers